Holder evidence
50
SEC ownership of Royalty Pharma plc
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001802768.
Lead holder
Legorreta G. Pablo
13D/G signal
Legorreta G. Pablo
Latest evidence
14 May 2026
- CIK
- 0001802768
- Symbol
- RPRX on Nasdaq
- Location
- New York, NY
- SEC evidence mix
- 13D/G, 3/4/5, and 13F
- Lead holder
- Legorreta G. Pablo
- Latest large-stake holder
- Legorreta G. Pablo
- Latest evidence date
- 14 May 2026
Issuer identity
Ownership snapshot
Ownership snapshot
Top shareholders of Royalty Pharma plc (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
Legorreta G. Pablo
13D/G signal
Legorreta G. Pablo
Evidence rows
50
Latest as of
14 May 2026
13D/G
3/4/5
13F
Lead comparable stake: 20%
13D/G row: Legorreta G. Pablo
Showing 1-8 of 50 holder rows.
Rank 1 holder
Legorreta G. Pablo
13D/G
3/4/5
- Ownership
- 20%
- Position
- $3.37B
Rank 2 holder
MORGAN STANLEY
13F
13D/G
- Ownership
- 9.2%
- Position
- $2.09B
Rank 3 holder
Capital International Investors
13F
13D/G
- Ownership
- 8.8%
- Position
- $1.68B
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Legorreta G. Pablo |
13D/G
3/4/5
CEO, Chairman of the Board, Director
|
20%
|
$3,372,819,557
103,112,796 shares
|
$0 | 16 May 2025 |
| MORGAN STANLEY |
13F
13D/G
Company
|
9.2%
from 13D/G
|
$2,090,131,406
43,571,633 shares
|
— | 31 Mar 2026 |
| Capital International Investors |
13F
13D/G
Company
|
8.8%
from 13D/G
|
$1,679,225,156
35,005,736 shares
|
— | 31 Mar 2026 |
| FMR LLC |
13F
13D/G
Company
|
6.5%
from 13D/G
|
$1,206,553,066
25,152,242 shares
|
— | 31 Mar 2026 |
| BlackRock, Inc. |
13F
13D/G
Company
|
5.7%
from 13D/G
|
$1,242,794,508
25,907,745 shares
|
— | 31 Mar 2026 |
| Severgnini Achille G. |
13D/G
|
5.7%
|
$978,612,513
24,223,082 shares
|
-$230,404,755 | 06 Nov 2025 |
| GENERAL ATLANTIC, L.P. |
13D/G
|
3.2%
|
$510,500,301
14,243,870 shares
|
$0 | 30 Jun 2025 |
| VANGUARD GROUP INC |
13D/G
The Vanguard Group
|
2.5%
|
$385,841,061
10,936,538 shares
|
$0 | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$64,551,698.
Buys
$0
Insiders: 0
Sells
$64,551,698
Insiders: 4
Net
-$64,551,698
Shares: -1,561,889
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 1,561,889
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 233,976 | $0 | $11,710,351 | -$11,710,351 |
| 3-6 | 0 | 1,019,811 | $0 | $41,017,108 | -$41,017,108 |
| 6-9 | 0 | 274,602 | $0 | $10,610,491 | -$10,610,491 |
| 9-12 | 0 | 33,500 | $0 | $1,213,749 | -$1,213,749 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 25 reporting-owner rows connected to Royalty Pharma plc. Open a relationship link for the CIK-to-CIK filing trail.
Rows
25
Lead holder
Legorreta G. Pablo
Net 12M change
-$64,551,698
Latest report
26 May 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Legorreta G. Pablo | CEO, Chairman of the Board, Director | $2,828,861,031 | Mixed | 06 May 2026 | ||
| GG 1978 SICAF SIF S.A. | 10%+ Owner | $608,282,853 | Mixed | 14 Sep 2022 | ||
| GG 1978 SICAF SIF S.A. - GG Strategic | 10%+ Owner | $590,239,561 | Mixed | 20 Sep 2022 | ||
| George W. Lloyd | EVP, Investments & CLO | $300,616,992 | -$13,807,997 | -4.4% | Mixed | 17 Dec 2025 |
| Terrance P. Coyne | Evp & Cfo | $233,519,976 | -$38,310,356 | -14% | Mixed | 26 May 2026 |
| Mario Germano Giuliani | Director, 10%+ Owner | $96,010,741 | Mixed | 23 Jun 2023 | ||
| William E. Ford | Director | $71,241,786 | Mixed | 30 Jun 2021 | ||
| Avara Management Ltd | 10%+ Owner | $68,463,141 | Mixed | 29 Dec 2023 | ||
| Christopher Hite | EVP & Vice Chairman | $37,387,770 | Median | 06 May 2026 | ||
| James F. Reddoch | EVP & Chief Scientific Officer | $23,300,586 | Mixed | 28 Sep 2022 | ||
| Rory B. Riggs | Director | $11,577,870 | Mixed | 20 Feb 2024 | ||
| Gregory Norden | Director | $10,165,559 | -$1,375,134 | -12% | Filing P/S | 14 May 2026 |
| Errol B. Desouza | Director | $4,828,170 | Mixed | 13 May 2025 | ||
| Henry A. Fernandez | Director | $4,190,575 | Mixed | 30 Jun 2025 | ||
| Ted W. Love | Director | $3,118,018 | Mixed | 13 May 2025 | ||
| Catherine M. Engelbert | Director | $2,948,893 | Mixed | 13 May 2025 | ||
| Bonnie L. Bassler | Director | $2,857,312 | Mixed | 31 Mar 2026 | ||
| Marshall Urist | EVP, Research & Investments | $1,872,289 | -$11,058,211 | -86% | Mixed | 20 May 2026 |
| David C. Hodgson | Director | $1,842,120 | Mixed | 13 May 2025 | ||
| Vlad Coric | Director | $344,996 | Mixed | 13 May 2025 |
Recent insider transactions for Royalty Pharma plc
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Reported value | Reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -100% | $3,476,116 | $53.98 | -64,399 | 0 | 26 May 2026 | TPC RP EPA1 LLC |
| Marshall Urist | RPRX | Class A Ordinary Shares | Sale | -42.9% | $721,838 | $52.75 | -13,684 | 18,197 | 20 May 2026 | Direct |
| Marshall Urist | RPRX | Class A Ordinary Shares | Sale | -30% | $726,137 | $53.06 | -13,684 | 31,881 | 14 May 2026 | Direct |
| Gregory Norden | RPRX | Class A Ordinary Shares | Sale | -1.56% | $161,385 | $53.00 | -3,045 | 191,803 | 14 May 2026 | Direct |
| Pablo G. Legorreta | RPRX | Class A Ordinary Shares | Award | 13.1% | 143,821 | 1,242,604 | 06 May 2026 | Direct | ||
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Award | 60.4% | 24,263 | 64,399 | 06 May 2026 | TPC RP EPA1 LLC | ||
| Christopher Hite | RPRX | Class A Ordinary Shares | Award | 3.54% | 24,263 | 709,399 | 06 May 2026 | By SCH Investment Partners LLC | ||
| Marshall Urist | RPRX | Class A Ordinary Shares | Award | 66.5% | 18,197 | 45,565 | 06 May 2026 | Direct | ||
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -4.46% | $93,334 | $49.78 | -1,875 | 40,136 | 28 Apr 2026 | TPC RP EPA1 LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -100% | $1,638,506 | $49.78 | -32,916 | 0 | 28 Apr 2026 | By TPC RP 2021, LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -50% | $1,590,890 | $48.33 | -32,916 | 32,916 | 01 Apr 2026 | By TPC RP 2021, LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -4.27% | $90,622 | $48.33 | -1,875 | 42,011 | 01 Apr 2026 | TPC RP EPA1 LLC |
| Bonnie L. Bassler | RPRX | Class A Ordinary Shares | Award | 1.11% | 815 | 73,947 | 31 Mar 2026 | Direct | ||
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -4.1% | $85,366 | $45.53 | -1,875 | 43,886 | 23 Mar 2026 | TPC RP EPA1 LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -33.3% | $1,498,623 | $45.53 | -32,916 | 65,832 | 23 Mar 2026 | By TPC RP 2021, LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -3.94% | $87,713 | $46.78 | -1,875 | 45,761 | 02 Mar 2026 | TPC RP EPA1 LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -25% | $1,539,821 | $46.78 | -32,916 | 98,748 | 02 Mar 2026 | By TPC RP 2021, LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -3.79% | $84,968 | $45.32 | -1,875 | 47,636 | 23 Feb 2026 | TPC RP EPA1 LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -20% | $1,491,638 | $45.32 | -32,916 | 131,664 | 23 Feb 2026 | By TPC RP 2021, LLC |
| Pablo G. Legorreta | RPRX | Class A Ordinary Shares | Award | 16.8% | 157,828 | 1,098,783 | 11 Feb 2026 | Direct | ||
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Award | 116.4% | 26,626 | 49,511 | 11 Feb 2026 | TPC RP EPA1 LLC | ||
| Christopher Hite | RPRX | Class A Ordinary Shares | Award | 4.04% | 26,626 | 685,136 | 11 Feb 2026 | By SCH Investment Partners LLC | ||
| Marshall Urist | RPRX | Class A Ordinary Shares | Award | 269.9% | 19,970 | 27,368 | 11 Feb 2026 | Direct | ||
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -4.53% | $47,059 | $43.29 | -1,087 | 22,885 | 04 Feb 2026 | TPC RP EPA1 LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -10.4% | $825,853 | $43.29 | -19,076 | 164,580 | 04 Feb 2026 | By TPC RP 2021, LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -20.5% | $265,413 | $42.84 | -6,195 | 23,972 | 03 Feb 2026 | TPC RP EPA1 LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -37.2% | $4,659,584 | $42.84 | -108,759 | 183,656 | 03 Feb 2026 | By TPC RP 2021, LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -16.2% | $245,896 | $42.08 | -5,843 | 30,167 | 02 Feb 2026 | TPC RP EPA1 LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -26% | $4,317,009 | $42.08 | -102,581 | 292,415 | 02 Feb 2026 | By TPC RP 2021, LLC |
| Marshall Urist | RPRX | Class A Ordinary Shares | Sale | -100% | $821,810 | $41.09 | -20,000 | 0 | 30 Jan 2026 | By Sandy Lamm LLC |
| Marshall Urist | RPRX | Class A Ordinary Shares | Sale | -50% | $805,110 | $40.26 | -20,000 | 20,000 | 23 Jan 2026 | By Sandy Lamm LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -9.43% | $147,556 | $39.35 | -3,750 | 36,010 | 20 Jan 2026 | TPC RP EPA1 LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -14.3% | $2,590,384 | $39.35 | -65,832 | 394,996 | 20 Jan 2026 | By TPC RP 2021, LLC |
| Marshall Urist | RPRX | Class A Ordinary Shares | Sale | -33.3% | $790,346 | $39.52 | -20,000 | 40,000 | 16 Jan 2026 | By Sandy Lamm LLC |
| Marshall Urist | RPRX | Class A Ordinary Shares | Sale | -25% | $815,634 | $40.78 | -20,000 | 60,000 | 09 Jan 2026 | By Sandy Lamm LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -8.62% | $144,059 | $38.42 | -3,750 | 39,760 | 02 Jan 2026 | TPC RP EPA1 LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -12.5% | $2,528,982 | $38.42 | -65,832 | 460,828 | 02 Jan 2026 | By TPC RP 2021, LLC |
| Marshall Urist | RPRX | Class A Ordinary Shares | Sale | -20% | $769,650 | $38.48 | -20,000 | 80,000 | 02 Jan 2026 | By Sandy Lamm LLC |
| Bonnie L. Bassler | RPRX | Class A Ordinary Shares | Award | 1.34% | 967 | 73,132 | 31 Dec 2025 | Direct | ||
| Marshall Urist | RPRX | Class A Ordinary Shares | Sale | -16.7% | $786,380 | $39.32 | -20,000 | 100,000 | 26 Dec 2025 | By Sandy Lamm LLC |
| Marshall Urist | RPRX | Class A Ordinary Shares | Sale | -14.3% | $767,582 | $38.38 | -20,000 | 120,000 | 19 Dec 2025 | By Sandy Lamm LLC |
| George W. Lloyd | RPRX | Class A Ordinary Shares | Sale | -100% | $1,180,053 | $38.50 | -30,654 | 0 | 18 Dec 2025 | By GWL 2014 G, LLC |
| George W. Lloyd | RPRX | Class A Ordinary Shares | Sale | -72.1% | $3,060,280 | $38.57 | -79,346 | 30,654 | 17 Dec 2025 | By GWL 2014 G, LLC |
| Marshall Urist | RPRX | Class A Ordinary Shares | Sale | -12.5% | $766,420 | $38.32 | -20,000 | 140,000 | 16 Dec 2025 | By Sandy Lamm LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -7.93% | $143,850 | $38.36 | -3,750 | 43,510 | 15 Dec 2025 | TPC RP EPA1 LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -11.1% | $2,525,322 | $38.36 | -65,832 | 526,660 | 15 Dec 2025 | By TPC RP 2021, LLC |
| Marshall Urist | RPRX | Class A Ordinary Shares | Sale | -71.2% | $714,224 | $39.15 | -18,242 | 7,398 | 05 Dec 2025 | Direct |
| Marshall Urist | RPRX | Class A Ordinary Shares | Sale | -12.7% | $913,591 | $39.15 | -23,334 | 160,000 | 05 Dec 2025 | By Sandy Lamm LLC |
| George W. Lloyd | RPRX | Class A Ordinary Shares | Sale | -50% | $4,375,008 | $39.77 | -110,000 | 110,000 | 03 Dec 2025 | By GWL 2014 G, LLC |
| Terrance P. Coyne | RPRX | Class A Ordinary Shares | Sale | -7.35% | $149,498 | $39.87 | -3,750 | 47,260 | 01 Dec 2025 | TPC RP EPA1 LLC |
* indicates a reported price that failed the local validity check.